Title of article
Mechanism of oral tolerance induction to therapeutic proteins
Author/Authors
Wang، نويسنده , , Xiaomei and Sherman، نويسنده , , Alexandra and Liao، نويسنده , , Gongxian and Leong، نويسنده , , Kam W. and Daniell، نويسنده , , Henry and Terhorst، نويسنده , , Cox and Herzog، نويسنده , , Roland W.، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2013
Pages
15
From page
759
To page
773
Abstract
Oral tolerance is defined as the specific suppression of humoral and/or cellular immune responses to an antigen by administration of the same antigen through the oral route. Due to its absence of toxicity, easy administration, and antigen specificity, oral tolerance is a very attractive approach to prevent unwanted immune responses that cause a variety of diseases or that complicate treatment of a disease. Many researchers have induced oral tolerance to efficiently treat autoimmune and inflammatory diseases in different animal models. However, clinical trials yielded limited success. Thus, understanding the mechanisms of oral tolerance induction to therapeutic proteins is critical for paving the way for clinical development of oral tolerance protocols. This review will summarize progress on understanding the major underlying tolerance mechanisms and contributors, including antigen presenting cells, regulatory T cells, cytokines, and signaling pathways. Potential applications, examples for therapeutic proteins and disease targets, and recent developments in delivery methods are discussed.
Keywords
TGF-? , Th3 , Nanoparticles , Tr1 , Oral delivery , transgenic plants , Protein antigen , dendritic cells , Treg , IL-10 , oral tolerance
Journal title
Advanced Drug Delivery Reviews
Serial Year
2013
Journal title
Advanced Drug Delivery Reviews
Record number
1763727
Link To Document